Moteur de recherche d’entreprises européennes
Financement de l’UE (3 956 399 €) : Matériaux sensibles aux stimuli pour la détection et le traitement rapides des infections nosocomiales Hor 16/09/2020 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Matériaux sensibles aux stimuli pour la détection et le traitement rapides des infections nosocomiales
Healthcare Associated Infections (HAIs) are bacterial infections obtained as a result of clinical treatment e.g. following medical intervention. HAIs are a problem of tremendous proportion as more than 4 million EC citizens get infected annually. The ECDC estimates 147,000 HAI-related deaths in Europe each year, a large part stemming from wound infections. These alarming facts motivate the urgent need to develop novel medical devices, in particular wound dressings, which rapidly signal and prevent or eradicate invasive bacterial colonization following a stimulus. Current antimicrobial coatings rely on slow, passive diffusion of antimicrobials, hence the antimicrobial may not be sufficiently concentrated to eradicate the infection; such low concentration zones promote evolution of resistance. To tackle these challenges in healthcare in light of an increasingly aging population and unprecedented antibiotic resistance levels, there is an urgent need for dedicated research leaders in industry and academia. These scientists of the future still will need primary training in, e.g., chemistry or microbiology, but they will have to operate at the interface between disciplines. Future materials chemists will need to perform microbiology experiments and to appreciate the engineering required to translate a lab invention to a production prototype. They have to understand the societal, business and regulatory environment around new medical device development. The research focus of STIMULUS is on wound infections. The objectives are: 1) Diagnostic: To create materials that clearly and rapidly signal when infection is present; 2) Therapeutic: triggered release of antimicrobials to treat the infection; 3) Translational and theranostic: integration of responsive materials into prototype wound dressings. Integrated with this research, we will create a lasting and comprehensive training programme for ESRs, making them suitable for leading research on theranostic medical devices.
| Atto-TEC GmbH | 252 788 € |
| Department of Health | 303 173 € |
| KOC University | 470 496 € |
| Paul Hartmann AG | 252 788 € |
| Stichting Amsterdam UMC | 531 240 € |
| Technische Universitat Darmstadt | 505 577 € |
| Universitaet Fuer Bodenkultur Wien | 528 414 € |
| Universitaet Siegen | 505 577 € |
| University of Bath | 606 345 € |
https://cordis.europa.eu/project/id/955664
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.